CHI’s 4th Optimizing bioassays for biologics conference

Bioassays are a critical component of biologics drug discovery and development. With increasingly complex biologic modalities coming to market, including those with multiple mechanisms, accurate biological measurements are crucial. Cambridge Healthtech Institute’s Fourth Annual Optimizing Bioassays for Biologics conference will showcase strategies for biologics with multiple modes of action while bridging two perspectives on bioassay development: biology and statistics.

At this event, industry leaders will showcase strategies for assay selection, validation, transfer, and maintenance with an emphasis on molecules with complex mechanisms. Health authorities will weigh in on new guidelines as well as provide insight into what they consider a well-characterized biologic.

Finally, new technologies and bioassay formats will be presented along with recommendations for implementation to ensure a steady drug development pipeline.